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Abstract 
Background: Tityus serrulatus venom (Ts venom) is a complex mixture of several 
compounds with biotechnological and therapeutical potentials, which highlights the 
importance of the identification and characterization of these components. Although 
a considerable number of studies have been dedicated to the characterization of 
this complex cocktail, there is still a limitation of knowledge concerning its venom 
composition. Most of Ts venom studies aim to isolate and characterize their neurotoxins, 
which are small, basic proteins and are eluted with high buffer concentrations on cation 
exchange chromatography. The first and largest fraction from carboxymethyl cellulose-52 
(CMC-52) chromatography of Ts venom, named fraction I (Fr I), is a mixture of proteins 
of high and low molecular masses, which do not interact with the cation exchange resin, 
being therefore a probable source of components still unknown of this venom. Thus, 
the present study aimed to perform the proteome study of Fraction I from Ts venom, 
by high resolution mass spectrometry, and its biochemical characterization, by the 
determination of several enzymatic activities. 
Methods: Fraction I was obtained by a cation exchange chromatography using 50 mg of 
crude venom. This fraction was subjected to a biochemical characterization, including 
determination of L-amino acid oxidase, phospholipase, hyaluronidase, proteases 
activities and inhibition of angiotensin converting enzyme (ACE) activity. Fraction I 
was submitted to reduction, alkylation and digestion processes, and the tryptic digested 
peptides obtained were analyzed in a Q-Exactive Orbitrap mass spectrometer. Data 
analysis was performed by PEAKS 8.5 software against NCBI database. 
Results: Fraction I exhibits proteolytic activity and it was able to inhibit ACE activity. 
Its proteome analysis identified 8 different classes of venom components, among them: 
neurotoxins (48%), metalloproteinases (21%), hypotensive peptides (11%), cysteine-rich 
venom protein (9%), antimicrobial peptides (AMP), phospholipases and other enzymes 
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Conclusions: The combination of a proteomic and biochemical characterization 
strategies leads us to identify new components in the T. serrulatus scorpion venom. 
The proteome of venom ś fraction can provide valuable direction in the obtainment of 
components in their native forms in order to perform a preliminary characterization 
and, consequently, to promote advances in biological discoveries in toxinology.
Background
Scorpion venoms are a rich source of components with diverse 
biological activities and high specificity for their targets [1]. 
Their venoms are usually composed of insoluble mucus, 
oligopeptides, mucopolysaccharides, nucleotides, low molecular 
weight molecules (serotonin or histamine), protease inhibitors, 
histamine releasers, amino acids and other organic compounds, 
enzymes and many neurotoxins [2-4]. Among this impressive 
cocktail, neurotoxins are the main components studied, mostly 
because of their interaction with Na+ or K+ channels and their 
importance in the scorpion envenoming [5]. In addition, several 
enzymes have been characterized in scorpion venoms, including 
phospholipase A, hyaluronidase, sphingomyelinase D, lysozyme, 
metalloproteases and serine proteases. Other enzymes have been 
related with the post-translational processing of toxin precursors 
and with the facilitation of venom permeation into tissues [3, 6]. 
The study of venom components is highly useful for elucidating 
the biochemical process of envenoming, but also for identifying 
molecules that can be used as molecular tools and/or drugs with 
therapeutic action. So far, the number of distinct toxins present 
in scorpion venoms has been estimated at about 100.000, and 
only less than 1% has been characterized [7, 8]. 
The initial fractionation of Tityus serrulatus (Ts) venom on 
a carboxymethyl cellulose-52 (CMC-52) column, described 
by Arantes et al. [9] and modified by Cerni et al. [5], uses 
ammonium bicarbonate buffer, pH 7.8, and allows separate Ts 
venom components in 18 fractions, according to their charge. 
The positively charged proteins at this pH (such as neurotoxins) 
interact with the cation exchange resin and the other proteins are 
eluted in the first fractions of the chromatography. Fraction I (Fr 
I) is the first and largest peak eluted on CMC-52 chromatography 
and was never in depth studied before. It is composed by a 
mixture of proteins of high and low molecular masses, being a 
probable source of components still unknown of T. serrulatus 
venom  and, therefore, was chosen to be  analyzed in this study [9]. 
Proteomic techniques have been employed to explore the 
diversity of toxins present in scorpion venom. Protein separation 
techniques, such as high performance liquid chromatography 
(HPLC) hyphened with soft ionization mass spectrometers, 
allowed a more detailed proteomic analysis of animal venoms 
[1, 10-18]. Those techniques provide a broad range of  structural 
information such as the amino acid sequence for peptides, 
accurate determination of molecular mass, determination of 
disulfide bonds, and characterization of post-translational 
modifications [19]. Furthermore coupled techniques such as 
chromatography and electrospray ionization (ESI) permit mass 
spectrometry to become the method of choice for the analysis 
of complex mixtures such as animal venoms [20]. 
With the advent of omics techniques, studies of animal venoms 
have become increasingly faster and more comprehensive, often 
able to provide a holistic view of all components in the venom 
specially when combined to Next Generation Sequencing 
(NGS) transcriptomics [21]. Therefore, due the high complexity 
of scorpion venoms, a proteome fraction-directed or fraction 
subproteomes combined to shotgun proteomics can be useful in 
the identification of new molecules and to guide the obtainment of 
components in their native forms in order to perform a preliminary 
characterization.  Considering this panorama, the present study 
carried out a high resolution proteome of Fraction I, the first 
fraction of the cation exchange chromatography from Tityus 
serrulatus venom, and its biochemical characterization, aiming 
the exploration and bioprospection of undiscovered components.
Methods
Venom Fractionation
Ts venom was obtained from the vivarium of the Faculdade de 
Medicina de Ribeirão Preto da Universidade de São Paulo (School 
of Medicine of Ribeirão Preto, University of São Paulo, Brazil), 
using electrical stimulation of 12 mV. The freeze-dried venom 
was diluted in ultra pure water (MilliQ®) and desiccated for 6 
h. After this procedure, the sample (50 mg) was resuspended in 
500 μL of 50 mM ammonium bicarbonate buffer, pH 7.8, and 
centrifuged at 13,000 rpm for 10 min at 4 °C (Centrifuge 5415 
R). Ammonium bicarbonate buffer (500 μL) was added to the 
precipitate, the mixture was homogenized and centrifuged. 
This process was repeated twice. The supernatants from the 4 
extractions (final volume of 2.0 mL) were pooled, held at 4 °C 
for 12 hours, and centrifuged at 13,000 rpm for 10 minutes. At 
the end of this process, the soluble venom (without mucus) was 
submitted to a fast protein liquid chromatography (FPLC), using 
a CMC-52 microgranular column 1.6 x 100 cm (Whatman, UK), 
equilibrated with buffer A (50 mM ammonium bicarbonate, 
pH 7.8), as described by Cerni et al. [5].  The sample (2 mL) was 
initially eluted with buffer A, followed by a linear concentration 
gradient (0 to 100%) of buffer B (0.6 M ammonium bicarbonate, 
pH 7.8), under a flow rate of 0.5 mL/min and  temperature of 
25 °C. Absorbance was automatically recorded at 280 nm. All 
the fractions obtained were lyophilized and stored at −20ºC.
Eletrophoresis
The fractions obtained from the venom chromatography were 
analyzed by tricine sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (Tricine-SDS-PAGE) following the method used 
for ultra-low mass proteins [22]. It was used a 16.5% separating 
gel, overlaid by a 5% stacking gel. The gels were stained with 
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PlusOne Coomassie Blue PhastGel® R-350 (GE Healthcare, UK) 
and destained with 10% acetic acid (v/v). The ultra-low range 
molecular weight marker (Sigma-Aldrich Co., USA) was used.
Biochemical characterization
Phospholipase activity
Phospholipase activity was assessed in Petri dishes [23], with 
the following modifications: agarose was replaced by agar and 
erythrocytes were not used. Briefly, a gel containing 0.01 M 
CaCl2, egg yolk diluted in phosphate-buffered saline (PBS) at 
pH 7.2 in the ratio 1:3 (v/v), 1% bacteriological agar, and 0.005% 
sodium azide was prepared in Petri dishes. Then, 40 µL of the 
fraction was applied into 5-mm diameter holes made in the 
gel, followed by incubation at 37 °C overnight. The formation 
of translucent halos around the holes in the gel indicated 
phospholipase activity.
Proteolytic activity on azocasein
The azocaseinolytic activity was determined by colorimetric 
assay [24], in which 85 μL of an azocasein solution (5 mg/mL in 
50 mM Tris-HCl pH 8.0) were incubated with 10 μL of venom 
fraction (Fraction I: 47 μg/μL) in 50 mM Tris-HCl,  pH 8, and 5 μL 
of solution of 100 mM protease inhibitors (phenylmethylsulfonyl 
fluoride, PMSF and ethylenediamine tetraacetic acid, EDTA), 
for 90 minutes at 37 °C. Next, 200 μL of 5% trichloroacetic acid 
(TCA) (v/v) was added to the samples followed by centrifugation 
at 1000 xg for 5 minutes. Then, 150 μL of 0.5 M NaOH were 
added to the supernatants and read at 450 nm.
L-amino acid (LAAO) activity
LAAO activity was detected spectrophotometrically according 
to Kishimoto and Takahashi [25]. Each venom fraction was 
incubated with 2 mM o-phenylenediamine (Sigma-Aldrich 
Co., USA), 1 U/mL horseradish peroxidase (Sigma-Aldrich 
Co., USA), 5 mM L-leucine (Sigma-Aldrich Co., USA), and 
0.05 M Tris-HCl buffer, pH 7.0. Incubation was performed at 
37 ° C for 1 hour and then the reaction was quenched with 2 M 
H2SO4. The absorbance was determined on a microplate reader 
at wavelength of 492 nm, with reference to absorbance at 630 
nm. To determine the amount of H2O2 released, a calibration 
curve was made with H2O2 (0 - 10 mM). According to Kishimoto 
and Takahashi [25], 1 unit of LAAO activity is defined as the 
amount of enzyme required to produce 1 μmol of H2O2 per 
minute under the specified conditions.
Angiotensin Converting Enzyme (ACE) inhibitory 
activity
ACE inhibitory activity in vitro was evaluated following the 
procedures described by Li et al. (2005) and modified by 
Pinheiro-Júnior (2018) to miniaturize the methodology to 2 mL 
micro tubes [26, 27]. The mixture of 30 µL of 5 mM Hippuryl-His-
Leu (HHL, Sigma-Aldrich Co., USA) in 100 mM borate buffer, 
pH 8.3 (Sigma-Aldrich Co., USA), containing 300 mM NaCl, 
was incubated for 5 min, at 37 ºC, with 20 µL of each venom 
fraction solution. As negative control of inhibition (100% ACE 
activity), 20 µL of the same buffer was used. ACE (20 µL of 100 
mU/mL solution; Sigma-Aldrich Co., USA) was later added to 
the mixture, which was then incubated for 2 h, at 37 ºC. The 
reaction was stopped with addition of 20 µL of HCl 2 N. The 
hippuric acid (HA), formed during ACE catalysis, was quantified 
by the incubation with 120 µL of quinoline (Sigma-Aldrich Co., 
USA) and 40 µL of benzenesulfonyl chloride (BSC, SigmaAldrich 
Co., USA) for 30 min, at 30 ºC. The chromogen formed by HA-
quinoline-BSC was diluted with 250 µL of ethanol, followed 
by another incubation, under the same conditions. Then, 290 
µL of the mixture was transferred to a 96-well plate and the 
absorbance was measured at 492 nm in a microplate absorbance 
reader (Sunrise Basic TECAN, Austria). The percentage of ACE 
inhibitory activity was calculated by the multiplication by 100 
of the difference from the absorbance in the reaction without 
and with inhibitor divided by the difference of absorbance in 
the reaction without inhibitor and negative control. All the 
experiments were performed in triplicate.
Hyaluronidase activity
Hyaluronidase activity was quantitatively determined by the 
turbidimetric assay as described by Pukrittayakamee et al. [28], 
adapted to a 96-well microplate and under conditions described 
by Amorim et al. [29]. For this assay it was used acetate buffer 
(200 mM sodium acetate and 150 mM NaCl pH 6.0), 10 μg 
hyaluronan (0.5 mg/mL in water) and the fraction I to the final 
volume of 200 μL. The mixture was incubated for 30 min at 37 
°C, and the reaction was stopped with the addition of 100 μL of 
5% cetyltrimethylammonium bromide (CTAB) and 4% NaOH 
(w/v). Then, the absorbance of the mixture was read at 400 
nm in a microplate reader (Sunrise Basic, Tecan, Switzerland). 
Hyaluronidase activity was expressed as the percentage of 
hydrolyzed hyaluronan, considering the absorbance of the 
tube in which no hyaluronan was added as 100% of hydrolysis.
Inhibition/potentiation of trypsin and chymotrypsin 
activity
A possible inhibitor or enhancer of trypsin/chymotrypsin activity 
present in venom fraction was tested. The reaction mixture was 
prepared as described by the supplier (PBS, enzyme, venom and 
chromogenic substrate specific for each enzyme).  The assay 
was performed with bovine trypsin and α-chymotrypsin (1 
mg/50 mL, 0.001 M HCl; Sigma-Aldrich Co., USA), trypsin and 
α-chymotrypsin substrates (10 mg/mL N-p-Tosyl-Gly-Pro-Lys-
4-nitroanilide acetate salt and 0.2 mg/mL N-Succinyl-Ala-Ala-
Pro-Phe-p-nitroanilide, respectively; Sigma-Aldrich Co., USA), 
phosphate-buffered saline (PBS) pH 7.4, and Fraction I at two 
concentrations (1.90 mg/mL and 5.65 mg/mL). The substrate 
solution was prepared at the 1 mg/20 mL assay concentration 
in PBS. Volumes of 5 μL of bovine trypsin and α-chymotrypsin 
were tested with 5 μL of substrate in the 96-well samples at room 
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temperature with 100 μL PBS. The reaction mixtures were read 
at 410 nm to quantify the formation of p-nitroaniline (yellowish 
color) every 2 minutes during 200 minutes.
Statistical Analyses
Experimental data are presented as mean ± SD, and they were 
analyzed with the GraphPad Prism software, version 6.0 for 
Windows (GraphPad Software, La Jolla, USA, 2012), using 
Student’s t-test or ANOVA followed by Sidak post-hoc. Values 
of p < 0.05 were considered statistically significant.
Proteomics analysis
In solution digestion of Fraction I
The lyophilized Fraction I was dispersed with 200 μL ultrapure 
water. The sample remained in the water bath at 37 °C for 20 
minutes and then centrifuged for 5 minutes. The sample was 
quantified by RC-DC protein assay (Bio-Rad, USA) and the 
concentration found was 8 μg/mL. For reduction of the Fraction 
I, an aliquot of the lyophilized sample was re-suspended in 8 
mL of 25 mM NH4HCO3 and 2 μL of 100mM dithiothreitol 
and incubated for 1 hour at 56 °C and 300 rpm. For further 
alkylation, 1.5 μL of 500 mM iodoacetamide was added to the 
sample and incubated in the dark for 1 hour at room temperature. 
Then, the fraction sample was digested by trypsin in 50 mM 
NH4HCO3, pH 7.8, in a ratio of 1:50 and incubated overnight, 
at 37 °C, under shaking at 300 rpm. Reaction was stopped by 
adding 10% TFA (v/v) to the reaction mixture, and the sample 
was dried on speed vacuum. Sample was suspended in 20 µL of 
0.1% TFA (v/v) for desalting on ZipTip™ pipette tips with C18 
resin (Millipore, Darmstadt, Germany), using an acetonitrile/
water/TFA (49.8/50/0.2 v/v) solution as eluent.
Shotgun proteomics
For shotgun proteomics analysis, the digested material was 
analyzed in the Acquity UPLC® M-Class (Waters, Milford, MA, 
USA) coupled to the Q-Exactive Orbitrap™ Mass Spectrometer 
(Thermo Scientific, Bremen, Germany). The chromatographic 
system is equipped with a 100 μm x 25 cm monolithic PepSwift 
capillary column (Thermo Scientific, Waltham, MA, USA). The 
elution of the peptides was performed with a gradient of 3-50% 
solution B in 80 minutes (A: H2O / 0.1% FA; B: acetonitrile) in 
a flow rate of 0.7 mL/min.
Data analysis
Raw data was loaded into Peaks 8.5 software (Bioinformatics 
solutions, Waterloo, Canada) [30] with database created 
by the deposits with “Scorpion”  keyword from NCBI 
database downloaded in June 2018 (42,656 sequences). 
Carbamidomethylation was set as fixed modification, while 
oxidation (M) and amidation were set as variable modifications. 
The maximum missed cleavages were set at 3 for trypsin. Parent 
mass and fragment mass error tolerance were fixed at 5 ppm 
and 0.015 Da, respectively. False discovery rate (FDR) of 1% and 
unique peptide ≥2 were used for filtering out inaccurate proteins 
for the SPIDER search. Only peptides with −10lgP > 20 were 
used to detect the proteins from the database. The percentage 
of the venom components in the Fraction I was calculated over 
the total proteins detected using LC − MS/MS [31].
Results
Biochemical characterization
Ts venom was fractioned using a cation exchange column CMC-
52, resulting in 18 fractions (Fig. 1A). Fraction I is the first to be 
eluted during the chromatography and represents around 30 % 
of the soluble venom. According to the electrophoresis gel it is 
possible to observe that this fraction is rich on a wide range of 
molecular mass components (Fig. 1B).
Fraction I was subjected to different assays for the identification 
of proteases (serine proteases, metalloproteinases), L-amino 
acid oxidases, hyaluronidases and bradykinin potentiating 
peptides. Fraction I did not demonstrated phospholipase, 
hyaluronidase or LAAO activities (data not shown). However, 
it exhibits proteolytic activity, as evidenced by increased 
proteolysis in trypsin and chymotrypsin assays (Fig. 2A) and 
by the hydrolysis of azocasein substrate (Fig. 2B). The azocasein 
assay indicates that metalloproteinases (inhibition by EDTA) 
and serine proteases (inhibition by PMSF) are present in this 
fraction. In addition, Fraction I was also able to inhibit 77.4% 
of the ACE activity (Fig. 2C).
Proteomics
Mass spectrometry analyses resulted in 4,321 MS and 28,504 
MS/MS scans for Fraction I. After applying the parameters 
described in the Methods section, Fraction I presented 8,017 
Peptide Spectrum Matches and 882 peptide sequences that 
matched the database information. These peptides belong to 
66 proteins, among which 56 were identified with more than 2 
unique peptides and 10 proteins with 2 unique peptides. 
The peptides obtained by high resolution nano-LC-ESI-
MS/MS were de novo sequenced using the SPIDER algorithm 
dedicated to the searches into the “Scorpion” database created 
from NCBI in June 2018. We have considered as an accurate 
identification just the proteins that matched with at least 2 
unique peptides. Therefore, with the de novo sequencing, it was 
obtained 3,269 mass spectra’s, with represented in 95 proteins 
that matched with the database in the SPIDER section analysis. 
The full list of proteins and peptides found in this study is 
reported in Additional file 1.
The results obtained by the biochemical characterization 
corroborates the proteomics analysis. Among them, 48% were 
neurotoxins, 21% metalloproteinases, 11% hypotensive peptides 
and 9% cysteine-rich venom protein (CRISPs). In this analysis, 
Fraction I also showed to have antimicrobial peptides (AMPs), 
phospholipases and other enzymes, such as chymotrypsin and 
lysozymes, which represents 3% each of all venom components 
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identified. In addition, it was identified phosphodiesterases (2%) 
in this fraction (Fig. 3).  
Fraction I presents several components of high molecular 
mass, such as enzymes and CRISPs, since it is possible to 
observe in the electrophoresis gel. The proteomic study 
identified 8 different venom components classes. De Oliveira et 
al. [32] described an integration of proteome and transcriptome 
studies of T. serrulatus and found 14 different classes of venom 
components, herein we found that 8 of them exist in Fraction 
I. In addition, it was observed the presence of peptides, 
such neurotoxins, hypotensive peptides and AMPs, which 
probably eluted in this fraction aggregated to other venom 
components.  Fraction I is the first to be eluted during the 
process of fractionation of the venom in a CMC-52 cationic 
resin, this fact indicates that it is composed of toxins with less 
basic characters than the others.
Related to ACE inhibition observed in the biochemical 
analysis, the proteome revealed 11% hypotensive peptides, 
including bradykinin-potentiating peptides, hypotensins, 
PAPE peptides and one endothelin-converting enzyme 1. The 
higher coverage of this class was obtained for the Hypotensin-2 
(P84190.1), already described by Verano-Braga et al. [33], with 
48 peptides sequenced that matched with the 25 amino acids 
residues from this template. However, the de novo sequencing 
showed 210 de novo tags for this template, resulted from at 
least 22 amino acid residues mutations (Additional file 2). Also, 
Figure 1. A: Chromatographic profile of Tityus serrulatus venom in FPLC system with CMC-52 column. Fractionation of Ts venom (50 mg) was performed in a 
FPLC system with CMC-52 column, equilibrated with buffer A (50 mM ammonium bicarbonate, pH 7.8), under a flow rate of 0.5 mL/min and  25 °C. Sample (2 
mL) was initially eluted with buffer A, followed by a linear concentration gradient (0 to 100%) of buffer B (0.6 M ammonium bicarbonate, pH 7.8), represented by 
the green line. Volume collected per tube: 4.0 mL. B: Electrophoretic profile of the fractions from the CMC-52 chromatography in 16.5% Tricine-SDS-PAGE. Gel 
was stained with PlusOne Coomassie Blue PhastGel® R-350 and destained with 10% acetic acid (v/v).
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Figure 2. A: Trypsin and chymotrypsin activity assay in the presence of fraction I in two concentrations (1.90 mg/mL and 5.65 mg/mL). The absorbance was 
determined at 410 nm. *p<0.05 Fr I (5.65 mg/mL) + Trypsin + substrate vs Trypsin + substrate; #p<0.05 Fr I (1.90 mg/mL) + Trypsin + substrate vs Trypsin + 
substrate.  B: Proteolytic activity of Fraction I (10 μL, 47 μg/μL) over azocasein in the absence and presence of inhibitors of metalloprotease (EDTA) and serine 
protease (PMSF). The absorbance was determined at 450 nm. *p<0.05 Fr I + EDTA and Fr I + PMSF vs Fr I.  C: Inhibition assay of ACE activity by Fraction I 
(48.4 mg/mL). Reactions were read at 492 nm. *p<0.05 ACE + Fr I vs ACE. C-:  negative control; Fr: Fraction I. Values are expressed as mean ± SD.
Figure 3. Relative distribution of venom protein classes in Fraction I from Ts venom determined by shotgun-proteomics. AMPs: antimicrobial peptides; CRISPs: 
cysteine-rich secretory proteins; Other enzymes: lysozyme, chymotrypsin and peptidylglycine alpha-amidating monooxygenase.
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this sequence has 33 possible post-translational modifications, 
such as the formation of pyro-glutamic ring which hamper the 
sequencing of these peptides by Edman’s Degradation. 
In this study, we identified two peptides (YANLGEFPWMVFIR 
and SELDKNCSGFLLSPSFVLDHK) that matched with a 
putative venom chymotrypsin-like protease (AG85164.1) from 
Tityus bahiensis. These findings can explain the enhancing of 
proteolytic activity of trypsin and chymotrypsin observed in 
the biochemical analysis of this fraction. 
Interesting, the proteome analysis revealed the presence 
of several CRISPs which were never isolated before and were 
reported only in the proteomic study of De Oliveira et al. [32]. 
Herein, we found that this venom component class is eluted 
in Fraction I, which will be useful in directing the isolation 
procedure to obtain these toxins. In this study we have covered 
57% of the protein sequence identified by De Oliveira et al 
[32] (deposit JAW07031.1). This sequence presented 14 post-
translational modifications, including amidations, acetylation, 
among others (Fig. 4).
The proteome of  Fraction I identified  venom components 
classes that were described just in the transcriptome study of 
De Oliveira et al. [32], such as phospholipases A2, antimicrobial 
and bradykinin-potentiating peptides. This fact reinforces the 
importance of a previous fractionation of the venom in order to 
obtain a more accurate sequencing of the venom components 
in the proteomics studies. 
Figure 4. De novo sequencing of the CRISP identified in the Fraction I using the JAW07031.1 (putative cysteine-rich protein from Tityus serrulatus) as a template. 
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Discussion
Although the omics approaches provide a holistic (although not 
exhaustive) view of the venom composition from the animals, 
there is a gap in the obtainment of these components directly 
from the venom, mainly due the low yield of purified toxins 
from milked venom. Therefore, a proteome fraction-directed 
or fraction subproteomes associated to shotgun proteomics can 
overcome this challenge. 
In this study a preliminary fractionation of the Ts venom 
was performed using the cation exchange column CMC-52, 
as described by Arantes et al. [9] and Cerni et al. [5]. This 
fractionation is based on the electrostatic interaction between 
the sample components and the stationary phase at pH 7.8. 
The positively charged venom components interact with the 
negatively charged carboxymethyl groups of the resin and are 
eluted with the increase of the buffer concentration [9]. This 
Ts venom fractionation approach has some advantages, as the 
isolation of Ts1 (fraction XIII), corresponding to 16% of the 
soluble venom. In addition, enzymes, such as hyaluronidase and 
proteases, especially metalloproteinases, keep their activities 
under these chromatographic conditions [5].
The chromatographic fractionation of the Ts venom resulted 
in 18 fractions. Fraction I is the first to be eluted, indicating that 
it is composed by proteins with character less basic than the 
other ones that are eluted with higher buffer concentrations. This 
fraction is rich in venom components, showing many protein 
bands with different molecular masses, in the Tricine-SDS-
PAGE. Additionally, Fraction I corresponds to approximately 
30% of the Ts venom, being its major fraction. 
The proteolytic activity assays of fraction I in the presence 
of inhibitors reveal the presence of both metalloproteases 
(inhibited by EDTA) and serine proteases (inhibited by PMSF). 
The existence of these proteases in Ts venom was reported 
before in omics studies of De Oliveira et al [32] that found 16 
transcripts related to trypsin-like proteases and 1 sequence 
of trypsin-like serine protease in the T. serrulatus proteome. 
However, the chymotrypsin peptides found in our work 
represents the first evidence at protein level of the presence 
of this protease in the Ts venom. 
The function of scorpion venom proteases has not been fully 
elucidated yet. These enzymes can cleave proteins at specific 
sites of the amino acid sequence and are classified according 
to the key amino acid at the catalytic site or according to 
the need of the metal ion to perform its function [34]. These 
enzymes are important for cellular metabolism, since they 
participate in the post-translational process of removal of the 
signal peptides, among others [35]. 
Proteinases can also act as toxins and are well characterized 
in the venoms of spiders and snakes. Concerning T. serrulatus 
venom, in 2010, a metalloproteinase called antarease, showed 
to be able to penetrate into intact tissues and cleaves vesicle-
associated membrane proteins (VAMPs), which may alter 
vesicular transport and secretion mechanisms [36, 37]. Thus, 
antarease may be one of the compounds responsible for acute 
pancreatitis observed after envenoming with T. serrulatus 
[36]. Recently, ten novel metalloproteinases sequences were 
predicted after analysis of the T. serrulatus venom gland 
transcriptome, called metaloserrulases [38].
Fraction I was also able to inhibit the ACE activity in vitro, 
and its proteome identified several components classified as 
hypotensive peptides. Some of these peptides are responsible 
for inhibiting the angiotensin converting enzyme, which 
converts angiotensin I to angiotensin II, a potent vasoconstrictor 
peptide. In addition, ACE also inactivates bradykinin, which is 
a vasodilator peptide [39]. These concomitant actions lead to a 
decrease in blood pressure, thus demonstrating the importance 
of these peptides as a possible molecular tool and/or therapeutic 
drug. Numerous studies reported already the presence of 
hypotensive peptides in animal’s venom [27, 40, 41]. 
Several scorpion venom components act on the cardiovascular 
system. Among them natriuretic peptides [42], PAPE peptides 
[18],  non-disulfide-bridged peptides [43], bradykinin-
potentiating peptides (BPPs) and hypotensins [33, 44] which 
are peptides that exhibits hypotensive properties. In our study, 
we found in Fraction I all these peptides, with exception of 
natriuretic peptide. In addition, we identified endothelin-
converting enzyme, already found in the study of De Oliveira 
et al. [32]. Although endothelin is frequently considered as 
having a primarily cardiovascular role in the brain, the roles of 
this enzyme in the venom remains unclear [32, 45].
Another important result obtained from proteome of Fraction 
I was the identification of CRISP classes. This venom component 
has been already reported in other animal venom, such as snakes 
[46-48], spiders [49, 50] and scorpions [32, 51, 52]. The role of 
CRISPs in the venom remain unclear but they seem to interfere 
in the smooth-muscle contraction by inhibiting ion channels [53]. 
One CRISP identified in the transcriptome of T. serrulatus by 
De Oliveira [32] was sequenced in our study. These results show 
how subproteome can be effective to drive the researches in the 
isolation of components with biotechnological and therapeutic 
potential directly from the venom. 
It is worth mentioning that some basic neurotoxins, such as 
Ts1, which are also found in fractions eluted at higher buffer 
concentrations, have been identified in Fraction I. This result 
shows that these neurotoxins may aggregate with other venom 
proteins, preventing their interactions with the resin during 
the chromatographic process, justifying their presence also in 
Fraction I. These phenomena contribute to increase the diversity 
of components present in this fraction, confirming our initial 
hypothesis that this fraction deserved to be better studied due 
to its diversity in bioactive components.
Conclusion
The study of the venom components has a remarkable importance 
in the toxinology field, which allows identifying molecules 
with biotechnological and therapeutic potentials. A fraction 
subproteome associated to biochemical characterization has an 
important role in the venom elucidation. Shotgun proteomics 
described at least 8 different venom component classes in Fraction 
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I, among them proteases and hypotensive peptides, which were 
confirmed by enzymatic assays, revealing how complex is this 
fraction.   Venom subproteomes may serve as a roadmap to 
obtain specific venom components in their native forms and 
therefore perform its preliminary characterization, promoting 
advances and biological discoveries to toxinology field.
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